JE, B., DM, A., M, B., & JY, L. (2018). Participant characteristics and clinical trial decision-making factors in AIDS malignancy consortium treatment trials for HIV-infected persons with cancer (AMC #S006). HIV clinical trials, 19(6), 235. https://doi.org/10.1080/15284336.2018.1537349
Chicago Style (17th ed.) CitationJE, Burkhalter, Aboulafia DM, Botello-Harbaum M, and Lee JY. "Participant Characteristics and Clinical Trial Decision-making Factors in AIDS Malignancy Consortium Treatment Trials for HIV-infected Persons with Cancer (AMC #S006)." HIV Clinical Trials 19, no. 6 (2018): 235. https://doi.org/10.1080/15284336.2018.1537349.
MLA (9th ed.) CitationJE, Burkhalter, et al. "Participant Characteristics and Clinical Trial Decision-making Factors in AIDS Malignancy Consortium Treatment Trials for HIV-infected Persons with Cancer (AMC #S006)." HIV Clinical Trials, vol. 19, no. 6, 2018, p. 235, https://doi.org/10.1080/15284336.2018.1537349.